Cargando…

Small airway function measured using forced expiratory flow between 25% and 75% of vital capacity and its relationship to airflow limitation in symptomatic ever-smokers: a cross-sectional study

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is diagnosed and its severity graded by traditional spirometric parameters (forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) and FEV(1), respectively) but these parameters are considered insensitive for identifying early pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alobaidi, Nowaf Y, Almeshari, Mohammed, Stockley, James, Stockley, Robert Andrew, Sapey, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540854/ https://www.ncbi.nlm.nih.gov/pubmed/36202407 http://dx.doi.org/10.1136/bmjresp-2022-001385

Ejemplares similares

Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25–75/FVC) in COPD
por: Abston, Eric, et al.
Publicado: (2017)

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
por: Polosukhin, Vasiliy V, et al.
Publicado: (2021)

The prevalence of bronchodilator responsiveness of the small airway (using mid-maximal expiratory flow) in COPD - a retrospective study
por: Alobaidi, Nowaf Y., et al.
Publicado: (2022)

Diagnostic and clinical values of non-cardiac ultrasound in COPD: A systematic review
por: Alqahtani, Jaber S, et al.
Publicado: (2020)

DNA methylation is associated with airflow obstruction in patients living with HIV
por: Hernandez Cordero, Ana I, et al.
Publicado: (2021)

Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction
por: Arjomandi, Mehrdad, et al.
Publicado: (2018)

Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022)

Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12
por: Jackson, Victoria E, et al.
Publicado: (2016)

No association between DNA methylation and COPD in never and current smokers
por: de Vries, Maaike, et al.
Publicado: (2018)

Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study
por: Heraganahally, Subash S, et al.
Publicado: (2021)

Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care
por: Lambe, Tosin, et al.
Publicado: (2019)

Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
por: Marcon, Alessandro, et al.
Publicado: (2018)

Small airways dysfunction: The importance of utilising Z-scores to define MMEF abnormalities in clinical practice
por: Almeshari, Mohammed A., et al.
Publicado: (2023)

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD
por: Dicker, Alison J, et al.
Publicado: (2018)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
por: Brill, Simon E, et al.
Publicado: (2015)

Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
por: Almeshari, Mohammed A, et al.
Publicado: (2021)

Physiological tests of small airways function in diagnosing asthma: a systematic review
por: Almeshari, Mohammed A, et al.
Publicado: (2020)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
por: Lewis, Amy, et al.
Publicado: (2011)

Aclidinium inhibits human lung fibroblast to myofibroblast transition
por: Milara, Javier, et al.
Publicado: (2011)

Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
por: Yorke, J, et al.
Publicado: (2010)

Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema
por: Mimae, Takahiro, et al.
Publicado: (2014)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society
por: McNulty, William, et al.
Publicado: (2014)

The impact of chronic obstructive pulmonary disease on intensive care unit admission and 30-day mortality in patients undergoing colorectal cancer surgery: a Danish population-based cohort study
por: Platon, Anna Maria, et al.
Publicado: (2014)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
por: Deslee, Gaëtan, et al.
Publicado: (2014)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary
por: Leidy, N K, et al.
Publicado: (2014)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
por: Buhl, Roland, et al.
Publicado: (2015)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Comparison of oxygen uptake during cycle ergometry with and without functional electrical stimulation in patients with COPD: protocol for a randomised, single-blind, placebo-controlled, cross-over trial
por: Medrinal, Clément, et al.
Publicado: (2016)

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study
por: McKeever, Tricia M, et al.
Publicado: (2016)

Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial)
por: Chatwin, M, et al.
Publicado: (2016)

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
por: Frith, Peter A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cicg46orfb6agksp6oj966hpmg